ADVERTISEMENT

Corbevax

Corbevax vaccine gets WHO Emergency Use Listing authorisation

BE has recently received final approval from CDSCO to begin clinical trials of the XBB.1.5 variant vaccine in India.

16 January 2024, 12:52 IST

Corbevax vaccine gets WHO Emergency Use Listing authorisation

Corbevax vaccine gets WHO Emergency Use Listing authorisation

Corbevax vaccine gets WHO Emergency Use Listing authorisation

16 January 2024, 12:52 IST

Covishield + Corbevax booster protects against variants

Only 27 to 28 per cent of India's eligible population have taken the booster dose

25 December 2022, 10:59 IST

Corbevax as heterologous booster along wth Covishield more effective against Covid-19 variants: Research

Corbevax as heterologous booster along wth Covishield more effective against Covid-19 variants: Research

Covishield + Corbevax booster protects against variants

25 December 2022, 10:59 IST

Govt nod to Corbevax as heterologous Covid booster shot

This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country

10 August 2022, 18:28 IST

Covid-19: Corbevax to be introduced as "heterogeneous" booster in Covid vaccination programme from August 12

Covid-19: Corbevax to be introduced as "heterogeneous" booster in Covid vaccination programme from August 12

Govt nod to Corbevax as heterologous Covid booster shot

10 August 2022, 18:28 IST

NTAGI recommends Corbevax as Covid booster for adults

Corbevax is currently being used to inoculate children in the age group of 12 to 14 years under the Covid-19 Immunisation programme

02 August 2022, 13:21 IST

NTAGI recommends Corbevax as booster for adults vaccinated with Covishield, Covaxin

NTAGI recommends Corbevax as booster for adults vaccinated with Covishield, Covaxin

NTAGI recommends Corbevax as Covid booster for adults

02 August 2022, 13:21 IST

NTAGI may consider Corbevax as heterologous booster vax

DCGI on June 4 approved Corbevax as a precaution dose for those aged 18 and above

27 June 2022, 15:53 IST

NTAGI likely to consider Corbevax as booster for those vaccinated with Covishield, Covaxin

NTAGI likely to consider Corbevax as booster for those vaccinated with Covishield, Covaxin

NTAGI may consider Corbevax as heterologous booster vax

27 June 2022, 15:53 IST

DH Evening Brief: India approves Corbevax as 1st heterologous Covid booster; Police make third arrest in Hyderabad gang-rape case

Here are the top stories this evening.

04 June 2022, 13:33 IST

DH Evening Brief: India approves Corbevax as 1st heterologous Covid booster; Police make third arrest in Hyderabad gang-rape case

DH Evening Brief: India approves Corbevax as 1st heterologous Covid booster; Police make third arrest in Hyderabad gang-rape case

DH Evening Brief: India approves Corbevax as 1st heterologous Covid booster; Police make third arrest in Hyderabad gang-rape case

04 June 2022, 13:33 IST

Biological E cuts price of Corbevax to Rs 250 per dose

It would result in end users paying a price of Rs 400 a dose, including taxes and administration charges

16 May 2022, 08:58 IST

Biological E cuts price of its Covid-19 vaccine Corbevax to Rs 250 per dose

Biological E cuts price of its Covid-19 vaccine Corbevax to Rs 250 per dose

Biological E cuts price of Corbevax to Rs 250 per dose

16 May 2022, 08:58 IST

Corbevax vs Covovax jabs under 18 yrs: Which to choose?

The vaccines will join Bharat Biotech's Covaxin, which is currently available for inoculation of the 12-18 age group and has been given EUA for the 6-12 age group

30 April 2022, 11:28 IST

Corbevax vs Covovax Covid-19 jabs for those under 18 years: Which one to choose?

Corbevax vs Covovax Covid-19 jabs for those under 18 years: Which one to choose?

Corbevax vs Covovax jabs under 18 yrs: Which to choose?

30 April 2022, 11:28 IST

Covid vax of 12-14 age group sees low turnout on Day 1

Day one of the exercise saw children arriving largely through 'walk-in for vaccination' and the numbers were very few at session sites

16 March 2022, 09:53 IST

Covid vaccination of 12-14 age group sees low turnout on day 1

Covid vaccination of 12-14 age group sees low turnout on day 1

Covid vax of 12-14 age group sees low turnout on Day 1

16 March 2022, 09:53 IST

Corbevax vaccine trials on at three sites in Karnataka

Among the ten trial sites, three are in Karnataka - one in Belagavi and two in Mysuru

16 March 2022, 06:48 IST

Corbevax vaccine trials on at three sites in Karnataka

Corbevax vaccine trials on at three sites in Karnataka

Corbevax vaccine trials on at three sites in Karnataka

16 March 2022, 06:48 IST